AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Nvidia and Eli Lilly and Co. are partnering to create an artificial intelligence lab in the San Francisco Bay Area to ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

Explore the role of transcription factor biology in drug discovery and how it impacts our understanding of disease mechanisms ...

TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...